Thousands of Men Are Using Breath Mints to Get Rock Hard. Here’s How
Hims offers Hard Mints, a chewable erectile dysfunction treatment, alongside other ED options. The company provides online consultations, personalized treatment plans, and discreet shipping. Pricing starts at less than $2 a day, with subscription options. All treatments require a prescription after an online consultation with a licensed healthcare provider.
How this was made
The 30-second read
Why it matters
The Hard Mints launch expands Hims' product portfolio, potentially attracting users seeking non-pill options, but regulatory and adoption uncertainties temper impact.
Market read
A modest product innovation that could slightly differentiate Hims in the competitive ED market.
What to watch
Regulatory risk from lack of FDA approval for compounded drugs.
Background
Hims Health provides online telehealth services for erectile dysfunction and other conditions, offering prescription and subscription models.
Ticker impact
Hims launched a new chewable erectile dysfunction product called Hard Mints, a novel compounded formulation.
Small upside if market views the product as a growth catalyst.
The launch adds a new format but lacks FDA approval and scale data, limiting immediate impact.
Market effects
May encourage other telehealth firms to explore novel dosage forms for chronic conditions.
Limited to U.S. telehealth market where Hims operates.
Low global relevance; product is U.S.-focused.
Counterpoint
Consumers may prefer traditional pills; chewable mints could face adoption hurdles.
Key entities
- companyHims Health Inc.
U.S.-listed telehealth provider focusing on men's health.
